Department of Surgery, University of Maryland School of Medicine, 22 S. Greene St, S8B02, Baltimore, MD, 21201, USA.
Service de Chirurgie pédiatrique, CHU Gabriel Touré, Bamako, Mali.
World J Surg. 2020 Sep;44(9):2892-2902. doi: 10.1007/s00268-020-05567-2.
Typhoid fever incidence and complications, including intestinal perforation, have declined significantly in high-income countries, with mortality rates <1%. However, an estimated 10.9 million cases still occur annually, most in low- and middle-income countries. With the availability of a new typhoid conjugate vaccine licensed for children and recommended by the World Health Organization, understanding severe complications, including associated mortality rates, is essential to inform country-level decisions on introduction of this vaccine. This scoping review summarizes over 20 years of the literature on typhoid intestinal perforation in sub-Saharan Africa.
We searched EMBASE, PubMed, Medline, and Cochrane databases for studies reporting mortality rates due to typhoid intestinal perforation in children, under 18 years old, in sub-Saharan Africa published from January 1995 through June 2019.
Twenty-four papers from six countries were included. Reported mortality rates ranged from 4.6-75%, with 16 of the 24 studies between 11 and 30%. Thirteen papers included postoperative morbidity rates, ranging from 16-100%. The most documented complications included surgical site infections, intra-abdominal abscesses, and enterocutaneous fistulas. High mortality rates can be attributed to late presentation to tertiary centers, sepsis and electrolyte abnormalities requiring preoperative resuscitation, prolonged perforation-to-surgery interval, and lack of access to critical care or an intensive care unit postoperatively.
Current estimates of mortality related to typhoid intestinal perforation among children in sub-Saharan Africa remain unacceptably high. Prevention of typhoid fever is essential to reduce mortality, with the ultimate goal of a comprehensive approach that utilizes vaccination, improvements in water, sanitation, and hygiene, and greater access to surgical care.
在高收入国家,伤寒发病率和并发症(包括肠穿孔)显著下降,死亡率<1%。然而,每年仍估计有 1090 万例伤寒发生,大多数发生在中低收入国家。随着新的伤寒结合疫苗的问世,该疫苗已获得许可并被世界卫生组织推荐用于儿童,了解严重并发症(包括相关死亡率)对于国家一级决策引入该疫苗至关重要。本范围综述总结了 20 多年来撒哈拉以南非洲地区伤寒肠穿孔的文献。
我们在 EMBASE、PubMed、Medline 和 Cochrane 数据库中搜索了 1995 年 1 月至 2019 年 6 月期间在撒哈拉以南非洲地区报告 18 岁以下儿童因伤寒肠穿孔导致死亡率的研究报告。
从六个国家的 24 篇论文中纳入。报告的死亡率范围为 4.6-75%,其中 24 项研究中有 16 项在 11-30%之间。13 篇论文包括术后发病率,范围为 16-100%。最常见的并发症包括手术部位感染、腹腔脓肿和肠皮肤瘘。高死亡率可归因于三级中心就诊晚、需要术前复苏的败血症和电解质异常、穿孔至手术间隔时间延长,以及缺乏术后重症监护或重症监护病房的机会。
撒哈拉以南非洲地区儿童伤寒肠穿孔相关死亡率的当前估计仍然高得令人无法接受。预防伤寒至关重要,以降低死亡率,最终目标是采取综合方法,利用疫苗接种、改善水、卫生和个人卫生以及更多获得手术护理。